Effect of Water Intake on the DNA Adducts Formation
Proof of Concept of the Effect of Water Intake on the DNA Adducts Formation
1 other identifier
interventional
65
1 country
1
Brief Summary
The main purpose of the study is to assess the effect of water intake on the formation of 4-ABP DNA adducts.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2011
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2011
CompletedFirst Submitted
Initial submission to the registry
April 20, 2012
CompletedFirst Posted
Study publicly available on registry
April 24, 2012
CompletedOctober 10, 2016
October 1, 2016
5 months
April 20, 2012
October 7, 2016
Conditions
Keywords
Study Arms (2)
1= Intervention
OTHER2= Control
OTHERInterventions
Eligibility Criteria
You may qualify if:
- Male subjects 20 to 45 years old (bound included)
- Smoker with at least 15 cigarettes/day
- Subjects with body mass index between 18 and 27kg/m2 (bound included)
- Subjects with a 3-meal diet (breakfast, lunch, dinner)
- Subjects who have an easy daily access to internet
- Subjects able to communicate well with the investigator and willing to comply the requirement of the study
- Subjects who have signed the form of informed consent and are registered to the French national welfare system
You may not qualify if:
- Subjects presenting evidence or history of severe or acute disease which could affect the results of the study or the vital status
- Subject practising physical activity in an intensive way according to the investigator judgment.
- Subject with a history of metabolic disease or with acute or chronic gastrointestinal disease except appendicectomy
- Subjects with diagnosed urinary tract disease
- Subjects with diagnosed lung or respiratory disease
- Subjects consuming regularly more than 3 units of alcohol per day
- Subjects who take drugs or presenting drug addiction (cannabis, opioids, amphetamines.)
- Subjects presenting a situation interfering with the outcomes of the study according to the investigator opinion
- Subjects working with painting, dry cleaning, dyes, pesticides, aluminium or alphalt
- Subjects who eat charcoaled food more than three meals/week
- Subjects with a vegetarian diet
- Subjects under local or general treatment which can modify measurements performed in the study, in particular the assessment of the hydration status (diuretic intake, or treatment interfering with metabolism and nutrition behaviour)
- Subjects planning to stop or reducing smoking or change their cigarette brand within the next 3 months
- Subjects in a situation which in the investigator's opinion could interfere with optimal participation in the present study or could constitute a special risk for the subject
- Subjects having received 4500 euros indemnities for participation in clinical trials in the 12 previous months (including participation in the present study)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre CAP
Montpellier, France
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 20, 2012
First Posted
April 24, 2012
Study Start
February 1, 2011
Primary Completion
July 1, 2011
Study Completion
October 1, 2011
Last Updated
October 10, 2016
Record last verified: 2016-10